Yes, I mean, clearly where we can try to reuse some capacity that's coming available because of the GM sourcing decision, we'll do that. We will have to spend some CapEx in advance, not only just to support this new business award, but to support the backlog and new business that we have. As you remember, our current backlog sits at $875 million, but not next year but the year after that we've got $375 million in that given year. So there's some CapEx that's going to have to be spent to support that prior to some of the other CapEx coming available for us from the GM T1XX sourcing type initiative. Again from a CapEx standpoint and from a capital management standpoint, again, you touched on it. The four areas: again, we're going to continue to focus on organic growth. There's a lot of opportunities when you look the $1 billion that we always essentially have in our market basket and the conversation rate that we're having on that right now, it's been very successful. The debt situation, Chris and Mike will continue to assess what we need to look at the debt side of things. Again, historically, this company has always run around the 1.5 time leverage type position. So we'll evaluate what that means to us, but we're not locked in to that. But again, all we want to do is shore up our balance sheet so that we can: one, be in a position that we can do strategic activities; or, two, deal with any business cycle turn that may or may not happen in the near future. And then as far as the shareholder side of things, obviously we always look at the shareholder side of things from an activity, whether it be a dividend or a stock buyback. But right now, our priority is lying more with the first three, that being organic growth, strengthen the balance sheet, or paying down the debt, and then now starting to look heavily into the strategic side.